Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19772738717external-prioritypatent/DE2738717A1/de
Priority claimed from DE19772758025external-prioritypatent/DE2758025A1/de
Priority claimed from DK377678Aexternal-prioritypatent/DK152753C/da
Application filed by Bayer AgfiledCriticalBayer Ag
Publication of DK285084D0publicationCriticalpatent/DK285084D0/da
Publication of DK285084ApublicationCriticalpatent/DK285084A/da
Publication of DK152123BpublicationCriticalpatent/DK152123B/da
Application grantedgrantedCritical
Publication of DK152123CpublicationCriticalpatent/DK152123C/da
DK285084A1977-08-271984-06-08Analogifremgangsmaade til fremstilling af 3,4,5-trihydroxypiperidinderivater eller farmaceutisk acceptable salte eller stereoisomere deraf
DK152123C
(da)
Analogifremgangsmaade til fremstilling af 2-hydroxymethyl-3,4,5-trihydroxypiperidinderivater eller farmaceutisk acceptable salte eller stereoisomere deraf
Analogifremgangsmaade til fremstilling af 2-hydroxymethyl-3,4,5-trihydroxypiperidinderivater eller farmaceutisk acceptable salte eller stereoisomere deraf
Analogifremgangsmaade til fremstilling af 5,11-dihydro-6h-pyrido-(2,3-b)(1,4)benzodiazepin-6-oner, der er substitueret i 11-stillingen, eller salte deraf
Analogifremgangsmaade til fremstilling af n-(5-tetrazolyl)-4-oxo-4h-pyrimido(2,1-b)benzothiazol-3-carboxamider eller farmaceutisk acceptable salte deraf med baser
Analogifremgangsmaade til fremstilling af 2,3-polymethylen-4-oxo-4h-pyrido- eller -azepinooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf